Latest Operational Improvement News

Appen Limited's FY25 results reveal solid revenue growth driven by generative AI projects and a standout performance from its China segment. The company sets FY26 revenue guidance of $270-300 million, underpinned by operational efficiencies and expanding AI data services.

Bendigo and Adelaide Bank reported a slight increase in its Common Equity Tier 1 ratio to 11.38% for the quarter ended March 2026, driven by net profit and capital inflows. Risk-weighted assets rose 1.75%, largely due to loan portfolio expansion and a new operational risk capital overlay.

Guzman y Gomez has abruptly exited the US market, citing financial underperformance despite brand progress, while reaffirming strong Australian growth and international franchise confidence.

Findi Limited lowers its FY26 operating revenue and EBITDA guidance, citing integration costs and funding delays, but reports operational improvements following a $25 million equity raise and appoints a new Chief Commercial Officer.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

Australian Dairy Nutritionals has locked in a $1.5 million secured loan facility with RELI Capital to shore up working capital and support its FY26 strategy, using its Yaringa dairy farm as collateral.

Novatti has successfully integrated Alipay into UNSW’s student payments portal, generating $33.6 million in transactions and $0.5 million in revenue by April 2026, positioning the company for broader expansion in the education sector.

My Food Bag Group Limited reported a steady 5% revenue increase for FY26, with net profit rising 5.3% amid improved customer retention and expanded product offerings. The company declared a fully imputed final dividend and initiated a strategic review of its ownership and capital structure.

OncoSil Medical has clinched TGA approval for its OncoSil™ device, the first Class III medical device targeting pancreatic tumours in Australia, paving the way for local commercialisation and enhanced patient access.

WA Kaolin has successfully recapitalised its balance sheet by approximately A$16.1 million through a partially underwritten entitlement offer and significant debt reduction, positioning the company for operational growth at its Wickepin kaolin project.

Contact Energy's April 2026 report shows rising electricity and gas sales, improved margins, and lower generation costs, supported by strong hydro storage and ongoing renewable projects.

Australian Dairy Nutritionals has closed the gap on its recent Entitlement Offer by placing 25 million shortfall shares, raising an additional $0.7 million and bringing total proceeds to $1.2 million.